Currently holds a position at Avadel Pharmaceuticals PLC
Position | Company | Period |
---|---|---|
Chief Financial Officer | Avadel Pharmaceuticals PLC | Dec. 2, 2019 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-16 | 2024-01-16 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
2,000
+2.5%
14.5029,000 USD |
2,000 +2.5% | 14.50 | 29,000 USD | |
2023-08-14 | 2023-08-14 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
2,000
+2.6%
14.4528,900 USD |
2,000 +2.6% | 14.45 | 28,900 USD | |
2022-11-30 | 2022-11-29 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
5,000
+7.0%
7.8039,000 USD |
5,000 +7.0% | 7.80 | 39,000 USD | |
2022-05-31 | 2022-05-27 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
50,000
+232.6%
2.14106,895 USD |
50,000 +232.6% | 2.14 | 106,895 USD | |
2020-09-21 | 2020-09-18 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
4,000
+22.9%
6.0024,000 USD |
4,000 +22.9% | 6.00 | 24,000 USD | |
2020-09-01 | 2020-08-28 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
7,500
+75.0%
6.7750,777 USD |
7,500 +75.0% | 6.77 | 50,777 USD | |
2020-08-17 | 2020-08-13 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
10,000
+inf%
7.7877,814 USD |
10,000 +inf% | 7.78 | 77,814 USD |